Cadrenal Therapeutics, Inc. · NASDAQ:CVKD

Pham Quang X sold 11,156 Cadrenal Therapeutics, Inc. shares (Form 4)

Traded Jun 25 to Jun 26, 2026 · Filed Jun 26, 2026

From Jun 25 to Jun 26, 2026, Pham Quang X (Director, Chairman, CEO and Interim CFO, 10% owner) sold 11,156 Cadrenal Therapeutics, Inc. shares at an average US$3.04 for US$33,919 under a trading plan, leaving 105,989 shares. Filed Jun 26, 2026 (Form 4).

Sold
11,156 shares
Price
US$3.04 average (US$3.00 to US$3.05)
Value
US$33,919
Holding after
105,989 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairman, CEO and Interim CFO, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 25, 2026Common StockSale2,127US$3.00115,018Direct
Jun 26, 2026Common StockSale9,029US$3.05105,989Direct

Source

View original at SEC

Related